Percutaneous transrenal ureteroneocystostomy.

Advanced cancer of the prostate causes mechanical obstruction of the ureteral orifice in 10% of patients. In our patient with advanced prostate carcinoma, after the usual method of placement of a ureteral stent had failed, antegrade percutaneous ureteroneocystostomy with placement of a double-J performed by means of the Lawson retrograde nephrostomy set. After removal of the stent 8 months later, the anastomosis functioned without a decrease in caliber until the patient died 2 years later.

Results in the treatment of renal tumours.

151 Patients having renal tumours were treated in our Urologic Department between 1975 and 1992; 86.1% of them were operated. Application of a new surgical method introduced in 1983, resulted achieving the level of international standards given in the literature: the survival of patients with tumours in stage of T1-T2 increased to 90%.

[Immunotherapy of superficial bladder tumors in a hospital department].

Since 1988 27 patients with bladder cancer - in the T1, G1, G2 stage - have been treated by intra-cavitally applied BCG (Pasteur). The follow-up period was 12-62 months. There was no relapse in 18 cases (66%) in 4 cases (16%) increase the average relapse rate, in 5 cases the treatment was unsuccessful.